Navitas Life Sciences is delighted to announce the formation of our new Advisory Board. This board will help shape and guide the strategy of Navitas Life Sciences working closely with the leadership team.
The advisory board is comprised of:
Steve Arlington
Steve has spent some 35 years in the pharmaceutical industry having worked for Smith Kline and French and Unilever. His most recent role was as Head of PWC’s Consulting Life Science Practice.
When asked why he chose to engage with Navitas, Steve said: “I am very pleased to be a member of the Advisory Board of Navitas. I love the challenge of building businesses and especially those where the teams are ready for a challenge and are highly motivated. The skills of the team and the focus of the business are really key to the future success of Pharma. The continued growth of the Nets and the unique value these deliver to members gives continuing insight into the challenges facing the industry. I feel there is plenty of scope to build on these, developing relevant services to meet current and future needs.”
Bruce Fadem
Bruce has spent some 20 years in the pharmaceutical industry, having retired as CIO for Wyeth in late 2005. Since retiring, Bruce has served as Chairman of Temple University Fox School of Business IT Advisory Board, and Editor in Chief for their Institute for Business and Information Technology (IBIT) Report.
When asked why he chose to engage with Navitas, Bruce said: “I joined the Advisory Board of Navitas Life Sciences because I am very impressed with the pharmaceutical industry expertise and experience, the focus and commitment to their clients, and the outstanding delivery record.”
Graham Higson
Graham has spent over 35 years in the pharmaceutical industry having held Senior Executive roles within Regulatory Affairs at GE Healthcare, AstraZeneca, and Pfizer.
When asked why he chose to engage with Navitas, Graham said: “I am excited to work with the Navitas Life Sciences team and particularly with the Nets, to help to drive the business forward. The pharmaceutical industry is facing many challenges and the expertise within the organisation can undoubtedly help address those in unique and compelling ways.”
Demi Lappas
Demi is a pharmaceutical veteran, having served as a CIO for Warner-Lambert, Pharmacia, and Enzon Pharmaceuticals.
When asked why he chose to engage with Navitas, Demi said: “Navitas Life Sciences brings to the table deep domain knowledge in clinical, regulatory, and data management which is unparalleled in the industry. If you add to that an excellent performance record in delivering value to customers, it makes for a compelling case for every Pharma company to include in their arsenal.”
Detailed biographies of our Advisory Board members can be found here
Navitas Life Sciences are domain experts in the areas of Clinical, Regulatory, Safety and Compliance with capabilities that cover; industry leading networks, strategic and change management consulting, technology, and BPO.